Trial of Melatonin to Improve Sleep in Children With Epilepsy and Neurodevelopmental Disabilities
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and efficacy of oral melatonin in
improving sleep continuity in children with epilepsy and neurodevelopmental delay who have
chronic insomnia by comparing Fast Release Melatonin (FR MLT) to placebo and Timed Release
Melatonin (TR MLT) with placebo in a randomized cross-over design trial.